<p>Cardiac arrest results in immediate interruption of blood flow. The primary goal of cardiopulmonary resuscitation (CPR) is to re-establish blood flow and hence oxygen delivery to the vital organs. This thesis describes different pharmacological interventions aimed at increasing cerebral blood flow during CPR and after restoration of spontaneous circulation (ROSC).</p><p>In a porcine model of cardiac arrest, continuous infusion of adrenaline generated higher cortical cerebral blood flow during CPR as compared to bolus administration of adrenaline. While bolus doses resulted in temporary peaks in cerebral blood flow, continuous infusion led to a sustained increase in this flow.</p><p>Administration of vasopressin resulted in higher cortical cerebral blood flow and a lower cerebral oxygen extraction ratio as compared to continuous infusion of adrenaline during CPR. In addition, vasopressin generated higher coronary perfusion pressure during CPR and increased the likelihood of achieving ROSC.</p><p>Parameters of coagulation and inflammation were measured after successful resuscitation from cardiac arrest. Immediately after ROSC, thrombin-antithrombin complex, a marker of thrombin generation, was elevated and eicosanoid levels were increased, indicating activation of coagulation and inflammation after ROSC. The thrombin generation was accompanied by a reduction in antithrombin. In addition, there was substantial haemoconcentration in the initial period after ROSC.</p><p>By administration of antithrombin during CPR, supraphysiological levels of antithrombin were achieved. However, antithrombin administration did not increase cerebral circulation or reduce reperfusion injury, as measured by cortical cerebral blood flow, cerebral oxygen extraction and levels of eicosanoids, after ROSC. </p><p>In a clinical study, the adrenaline dose interval was found to be longer than recommended in the majority of cases of cardiac arrest. Thus, the adherence to recommended guidelines regarding the adrenaline dose interval seems to be poor. </p>

The present thesis investigated family history and neurobiology of social phobia. Social phobia is a disabling disorder characterized by a marked fear of scrutiny in a variety of social situations. By using a validated questionnaire, study I related family history of excessive social anxiety to social phobia and avoidant personality disorder in epidemiologically identified probands in the Swedish general population. A two- to threefold increased relative risk of social anxiety was observed for both diagnostic groups. Thus, having an affected family member is associated with approximately a doubled risk for both social phobia and avoidant personality disorder. The neurobiological studies explored situational and anticipatory elicited anxiety by means of positron emission tomography and 15O-water. Study II examined the functional neuroanatomy of social anxiety provocation in social phobics and a healthy comparison group during a public speaking task. Social phobia symptomatology was associated with higher neural activity in the amygdaloid complex, i.e. "the alarm system" of the brain, and lower activity in the prefrontal cortex. Study III examined the neural correlates of anxiety elicited by the anticipation of public speaking in individuals with social phobia. Anticipatory anxiety was accompanied by enhanced regional cerebral blood flow in the dorsolateral prefrontal and inferior temporal cortices as well as in the amygdaloid-hippocampal region. Brain blood flow was lower in the temporal pole and in the cerebellum. These results suggest that social phobia has a neuroanatomical basis in a highly sensitive fear network centered in the amygdaloid-hippocampal region and encompassing the prefrontal cortex.

The present thesis explored the neurobiological basis of three aspects of defense behaviors in humans. Positron emission tomography methodology was used, and changes in regional cerebral blood flow (rCBF) were measured as an index of neural activity. Firstly, brain function was studied in a group of patients suffering from combat-related posttraumatic stress disorder, using a symptom provocation paradigm with combat sounds in order to elicit fear. Exposure to auditory trauma reminders relative to neutral sounds was associated with increased rCBF in sensorimotor areas, the cerebellar vermis, the periaqueductal gray matter, and the right amygdala, whereas decreased activity was observed in the retrosplenial area of the posterior cingulate cortex. Secondly, the neural circuitry mediating the acoustic startle response and its habituation was studied in a group of healthy subjects. During acoustic startle stimulation as compared to a resting condition, increased rCBF was found in a medial posterior area of the pons corresponding to the nucleus reticularis pontis caudalis. As a result of startle repetition, altered activity was found in the cerebellum, pointing to its involvement in startle habituation. Thirdly, neural activity associated with startle modulation by phobic fear was studied in a group of subjects with specific animal phobias during exposure to pictures of their feared and non-feared objects, paired and unpaired with acoustic startle stimuli. As a result of startle potentiation, increased rCBF was found in the left amygdaloid-hippocampal region, and medially in the affective division of the anterior cingulate cortex. In conclusion, these results provide evidence for the involvement of limbic and paralimbic brain areas during fear provocation and fear-potentiated startle and for a similar neurocircuitry underlying startle in humans and animals.

Cardiac arrest results in immediate interruption of blood flow. The primary goal of cardiopulmonary resuscitation (CPR) is to re-establish blood flow and hence oxygen delivery to the vital organs. This thesis describes different pharmacological interventions aimed at increasing cerebral blood flow during CPR and after restoration of spontaneous circulation (ROSC). In a porcine model of cardiac arrest, continuous infusion of adrenaline generated higher cortical cerebral blood flow during CPR as compared to bolus administration of adrenaline. While bolus doses resulted in temporary peaks in cerebral blood flow, continuous infusion led to a sustained increase in this flow. Administration of vasopressin resulted in higher cortical cerebral blood flow and a lower cerebral oxygen extraction ratio as compared to continuous infusion of adrenaline during CPR. In addition, vasopressin generated higher coronary perfusion pressure during CPR and increased the likelihood of achieving ROSC. Parameters of coagulation and inflammation were measured after successful resuscitation from cardiac arrest. Immediately after ROSC, thrombin-antithrombin complex, a marker of thrombin generation, was elevated and eicosanoid levels were increased, indicating activation of coagulation and inflammation after ROSC. The thrombin generation was accompanied by a reduction in antithrombin. In addition, there was substantial haemoconcentration in the initial period after ROSC. By administration of antithrombin during CPR, supraphysiological levels of antithrombin were achieved. However, antithrombin administration did not increase cerebral circulation or reduce reperfusion injury, as measured by cortical cerebral blood flow, cerebral oxygen extraction and levels of eicosanoids, after ROSC. In a clinical study, the adrenaline dose interval was found to be longer than recommended in the majority of cases of cardiac arrest. Thus, the adherence to recommended guidelines regarding the adrenaline dose interval seems to be poor.

Arterial spin labeling is a completely non-invasive method for blood-flow measurement techniques. Alzheimer's disease pathology includes microvascular abnormalities in addition to practically all risk factors having a vascular component that reduces cerebral perfusion. Hemodynamic parameters of cerebral blood flow and arterial transit time were estimated via single-compartment modeling of pseudo continuous arterial spin labeling data and neurocognitive test scores (Alzheimer's disease assessment scale and mini-mental state examination) were compared between a group of healthy (N=20) and early Alzheimer's disease (N=25) subjects before and six months after the Alzheimer's subjects began treatment with cholinesterase inhibitors. The early Alzheimer's group showed improved CBF after 6 months' treatment in every Alzheimer's-prone region except the medial and lateral temporal lobes. No difference in arterial transit time was found between groups, indicating that the pathophysiological process causing hypoperfusion in Alzheimer's disease may differ from vascular dementia.

Arterial spin labeling is a completely non-invasive method for blood-flow measurement techniques. Alzheimer's disease pathology includes microvascular abnormalities in addition to practically all risk factors having a vascular component that reduces cerebral perfusion. Hemodynamic parameters of cerebral blood flow and arterial transit time were estimated via single-compartment modeling of pseudo continuous arterial spin labeling data and neurocognitive test scores (Alzheimer's disease assessment scale and mini-mental state examination) were compared between a group of healthy (N=20) and early Alzheimer's disease (N=25) subjects before and six months after the Alzheimer's subjects began treatment with cholinesterase inhibitors. The early Alzheimer's group showed improved CBF after 6 months' treatment in every Alzheimer's-prone region except the medial and lateral temporal lobes. No difference in arterial transit time was found between groups, indicating that the pathophysiological process causing hypoperfusion in Alzheimer's disease may differ from vascular dementia.

Submitted by Biblioteca do Instituto Biomédico BIB (uffbib@gmail.com) on 2017-06-05T17:21:23Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertação_JOAODARIO.pdf.crdownload: 224743 bytes, checksum: 241e082c7654d24673c8cce10e478287 (MD5) / Made available in DSpace on 2017-06-05T17:21:24Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertação_JOAODARIO.pdf.crdownload: 224743 bytes, checksum: 241e082c7654d24673c8cce10e478287 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Exercício isométrico de preensão manual (EPM) está associado com aumento regional da perfusão cerebral. Caracterizada por mecanismos complexos, especulasse a contribuição do sistema nervoso simpático (SNS) na regulação do fluxo sanguíneo cerebral nessas condições. Assim, o objetivo deste estudo foi determinar a contribuição do SNS na distribuição do fluxo sanguíneo cerebral durante exercício de preensão manual. O fluxo sanguíneo de ambas artérias carótidas internas (ACI, Doppler) e pressão arterial (Finometer) foram simultaneamente determinados em nove homens jovens saudáveis (27±5 anos) em repouso e durante dois minutos de EPM (30% da contração voluntária máxima), sob controle e bloqueio alfaadrenérgico do tipo 1 (α1-bloqueio) (170 min após ingestão de Prazosin [50ug/kg]). Para confirmar a eficiência do bloqueio farmacológico, administrou-se fenilefrina intravenosa (FE-1ug/kg) antes, 150 minutos após a ingestão do Prazosin e ao final do protocolo. A pressão parcial ao final da expiração de CO2 (PetCO2, sistema de reinalação) foi controlada ao longo do estudo. Durante repouso, o fluxo sanguíneo de ambas ACI foi semelhante (p>0,05). No exercício, observou-se aumento da pressão arterial (p<0,05) e mudanças na distribuição regional do fluxo sanguíneo cerebral pelo aumento da perfusão da ACI contralateral (p<0,05). A condutância vascular também indicou uma distribuição regional do fluxo sanguíneo cerebral através de uma maior redução da perfusão na ACI ipsilateral (p<0,05). O Prazosin foi eficaz para induzir o bloqueio alfa adrenérgico do tipo 1. Durante o repouso na condição α1-bloqueio, a pressão arterial, o fluxo sanguíneo e condutância vascular não apresentaram diferença com o repouso da condição controle (P>0,05). Sob bloqueio alfa-adrenérgico do tipo 1, o EPM provocou uma menor resposta da pressão arterial (P<0,05). Foram observadas alterações similares na perfusão de ambas ACIs (p>0,05) assim como na redução da condutância (p>0,05). Estes resultados indicam a contribuição SNS na regulação do fluxo sanguíneo cerebral durante EPM. / Static Handgrip Exercise (SHG) is associated with increases in regional cerebral perfusion. Thus, the objective of this study was to determine the contribution of the SNS in the distribution of cerebral BF during SHG. The BF of the both internal carotid artery (ICA Doppler) and mean arterial pressure (MAP, Finometer) were simultaneously determined in 9 healthy young men (27 }5 years) at rest and during 2 minutes of SHG (30 % of the maximum voluntary contraction) under control (CT) and alpha1-adrenergic blockade (170 min after ingestion of Prazosin [50ug/kg]). To confirm the efficacy of pharmacologic blockade, intravenous phenylephrine (PE- 1ug/kg) was administered before, 150 minutes after Prazosin ingestion and at the end of protocol. End-tidal CO2 (rebreathing system) was monitored throughout the study. The BF of both ACI were similar (p>0.05) during rest. At exercise, the MAP increased (p<0.05) and changes in the distribution of regional cerebral BF were observed by an increase in perfusion of the contralateral ICA (p<0.05). Vascular conductance (VC) also indicated a regional distribution of cerebral BF through greater reduction of perfusion in the ICA ipsilateral (p<0.05). Prazosin was effective to induce alpha1-adrenergic blockade. During rest alpha1-adrenergic blockade, MAP, BF and VC showed no difference at rest to control condition (P>0.05). Under alpha1-adrenergic blockade, the SHG produced a lower MAP response (p<0.05), whereas similar changes were observed in both ICAs perfusion (p>0.05) as in conductance reduction (p>0.05). These results indicate the SNS contribuition to cerebral blood flow regulation during SHG.

L’imagerie fonctionnelle cérébrale détecte les changements hémodynamiques induits par un stimulus pour déterminer les zones d’activation neuronale. Plus particulièrement, l’imagerie BOLD en IRMf détecte les changements d’oxygénation du sang grâce aux propriétés paramagnétiques de la déoxyhémoglobine. L’oxygène n’est donc pas uniquement un substrat énergétique pour le tissu neuronal, il joue également un rôle majeur dans l’imagerie noninvasive du cerveau humain. Au cours de ma thèse, j’ai tout d’abord participé à la mise au point d’une nouvelle technique non-invasive d’imagerie de l’oxygène dans le cerveau d’animaux anesthésiés. Couplant un nouveau senseur phosphorescent de l’oxygène (Finikova et al., 2008) et la microscopie biphotonique, cette approche permet à la fois de cartographier l’oxygène en 3D avec une résolution spatiale et temporelle jusqu’alors inégalée, mais aussi de suivre simultanément l’oxygène et le flux sanguin dans les capillaires cérébraux au repos ou lors d’une activation neuronale (Lecoq et al., 2011). Tirant profit des nouvelles possibilités de cette technique, nous avons alors démontré: • la présence d’un shunt artério-veineux uniquement basé sur la diffusion de l’oxygène. Ce résultat, obtenu chez le rat dans la couche la plus superficielle du bulbe olfactif: la couche du nerf (ONL), confirme que l’oxygène ne diffuse pas uniquement à partir des capillaires et démontre que les artérioles contribuent significativement à l’oxygénation du tissu cérébral. Il démontre également qu’il n’est pas possible de déterminer ni la Po2 capillaire ni la Po2 tissulaire à partir de la Po2 veineuse. • l’existence de transitoires de Po2 associés à chaque globule rouge dans le compartiment capillaire, appelés EATs (erythrocyte-associated transients) (Hellums, 1977; Cabrales and Intaglietta, 2007). En bref, de part leur diamètre supérieur à celui de la lumière d’un capillaire, les globules rouges passent un à un dans la lumière des capillaires, laissant entre eux un espace de plasma. Cependant, la faible solubilité de l’oxygène dans le plasma crée une barrière à la diffusion, ce qui se traduit par une inhomogénéité de la Po2 capillaire: celle-ci est élevée au bord du globule rouge et décroit avec la distance pour atteindre un minimum à mi-distance entre deux globule rouges. Poursuivant l’étude des EATs (Parpaleix et al., 2013), nous avons observé les points suivants: • La Po2 tissulaire dans l’environnement immédiat d’un capillaire peut être déterminée à partir de la Po2 vasculaire à mi-distance entre deux érythrocytes. Ce résultat est intéressant en ce qu’il permettra d’effectuer des mesures non invasives de Po2 tissulaire, utile notamment chez l’animal éveillé. • L’amplitude des EATs est si large (35 mmHg en moyenne) que la Po2 capillaire moyenne ne reflète en rien la saturation en oxygène de l’hémoglobine. • Une empreinte filtrée des EATs vasculaires est détectable dans le tissu (_5 mmHg d’amplitude). • Au cours d’une stimulation neuronale, une diminution de la Po2 capillaire moyenne peut être détectée avant l’hyperémie fonctionnelle, un résultat jusqu’à présent controversé dans le domaine de l’imagerie BOLD en IRMf, mais important en ce que ce dip pourrait être un rapporteur très résolutif de l’activation neuronale. Parmi les questions restant en suspens et pouvant être étudiées finement avec notre approche, j’en citerai une principale: quel est le poids des différents facteurs (métaboliques, présynaptiques ou post-synaptiques) et du flux sanguin dans l’établissement de la Po2 cérébrale au repos? / In humans, functional mapping of brain activity mainly relies on the increase of cerebral blood flow (CBF) triggered by neuronal activation. This neurovascular coupling provides energy substrates such as oxygen and glucose to the activated area. The steady state concentration of oxygen, as well as its dynamics upon neuronal activation, have been investigated with numerous methods, however, none of them provided highly resolute measurements in depth. During my PhD, we combined a phosphorescence quenching approach with two-photon microscopy to detect, in depth and with a micrometer spatial resolution scale, the emission of phosphorescence by PtP-C343, a new oxygen nano-sensor designed for two-photon excitation. We first characterized the technique and then reported two biological results, using the olfactory bulb (OB) glomerulus as a model to study oxygen concentration, at rest and upon odor stimulation. We found an arterio-venous shunt, purely based on diffusion, in the superficial nerve layer of the OB, confirming the role of arterioles in brain oxygenation. Simultaneous measurements of Po2 and blood flow allowed us to reveal the presence of erythrocyte-associated transients (EATs), i.e. Po2 fluctuations that are associated with individual erythrocytes. Pursuing the investigation of EAT characteristics, we found that in capillaries, Po2 at mid-distance between two erythrocytes is at equilibrium with, and thus reports Po2 in the nearby neuropil. Finally, we could observe that even in capillaries, a small oxygen initial dip can be detected prior to functional hyperemia, upon odor activation.

A esquizofrenia continua sendo um dos transtornos mais desafiadores para a clínica psiquiátrica, apesar dos estudos atuais que tentam elucidar sua fisiopatologia e buscar novas opções de tratamento. A n-acetilcisteína (NAC) é uma droga utilizada há mais de 30 anos na clínica médica no tratamento da intoxicação por acetaminofeno e como mucolítico na DPOC, entre outros. Evidências recentes apoiam o seu uso no tratamento de diversos transtornos neuropsiquiátricos, como depressão, transtorno afetivo bipolar, dependência química e esquizofrenia. A droga tem como provável mecanismo de ação um aumento na atividade antioxidante através do aumento nos níveis de glutationa (GSH) e modulação da neurotransmissão glutamatérgica. Nas duas últimas décadas, o estudo dos mecanismos neurobiológicos subjacentes aos transtornos psiquiátricos, bem como a investigação dos possíveis mecanismos e regiões cerebrais influenciados por substâncias psicofarmacológicas, recebeu importante contribuição das técnicas de neuroimagem funcional. Apesar disto, até o momento existem poucos estudos que avaliaram os mecanismos centrais relacionados às propriedades antipsicóticas da NAC em humanos. Este estudo tem o objetivo de investigar os efeitos da NAC em indivíduos portadores de esquizofrenia refratária em uso exclusivo de clozapina através de medidas de sintomas positivos e negativos e da avaliação da perfusão cerebral através de ressonância magnética nuclear utilizando a técnica de arterial spin labeling (ASL). Foram avaliados 20 sujeitos com esquizofrenia refratária em uso de clozapina em um estudo com distribuição aleatória, duplo-cego e controlado por placebo, utilizando a dose de 2000mg por dia de NAC. Do total da amostra, 14 tiveram as imagens perfusão sanguínea cerebral analisadas. O estudo teve a duração de oito semanas, com avaliações a cada quatro semanas e realização das RMN no início e ao final do período. Não foram observadas diferenças estatisticamente significativas entre os grupos placebo e NAC nas escalas BPRS e PANSS-N. O grupo que recebeuNAC apresentou mais efeitos colaterais, porém no geral a medicação foi bem tolerada. Também não se observou diferenças no FSC das diversas ROI analisadas. A NAC não produziu mudanças estatisticamente significativas nas escalas de sintomas e no FSC nesta amostra, apesar de outros estudos mostrarem diferenças significativas favorecendo a NAC. O presente estudo não mostrou melhora do FSC, mesmo após oito semanas, o que pode significar que a ASL pode não ser um método adequado para avaliar os efeitos cerebrais desta droga / Schizophrenia continues to be one of the most challenging psychiatric disorders in the clinical practice, despite recent studies that attempt to elucidate its pathophysiology and search for new treatment options. N-acetylcysteine (NAC) is a drug that has been used for more than 30 years in clinical medicine, in situations like acetaminophen intoxication and as mucolytic in COPD, among others. Recent studies support its therapeutic use in neuropsychiatric disorders such as depression, bipolar disorder, substance abuse and schizophrenia. The mechanism of action of NAC seems to occur in antioxidant activity, through the increase of glutathione levels (GSH) and in the modulation of glutamatergic neurotransmission. In the last two decades, the study of the neurobiological mechanisms underlying psychiatric disorders, as well as the investigation of the possible mechanisms and brain areas influenced by psychopharmacological substances received a significant contribution of functional neuroimaging techniques. Despite this, there are few studies that have evaluated the central mechanisms related to the antipsychotic properties of NAC in humans. This study aims to investigate the effects of NAC in subjects with refractory schizophrenia, exclusively on clozapine use, through measure of positive and negative symptoms and the evaluation of cerebral perfusion by magnetic resonance imaging, using the arterial spin labeling technique (ASL) . Twenty subjects with refractory schizophrenia were evaluated in a randomized, double-blind, placebo-controlled study using a dose of 2000mg per day of NAC. From the total sample, 14 had cerebral perfusion images analyzed. The study had a duration of eight weeks, with evaluations at each four weeks and MRI sessions before the beginning of NAC and at the end of the period. The results did not show statistically significant differences between placebo and NAC groups onthe BPRS and PANSS-N scales. The NAC group presented more side effects, although the medication was well tolerated in general. There were also no differences in the cerebral blood flow (CBF) among the regions of interest analyzed. Although there was no difference regarding symptoms scales the CBF in this sample, other studies found differences favoring NAC. The present study did not show changes of the CBF, which might mean that ASL is not an adequate technic to evaluate neurochemical effects of this drug

Les études épidémiologiques ont associé la rigidité artérielle au déclin cognitif et à la démence. Cependant ses effets sur la biologie du cerveau restent méconnus. Dans notre première étude, en utilisant un nouveau modèle murin de rigidité artérielle, nous avons voulu caractériser les effets de la rigidité artérielle sur le cerveau indépendamment de l’âge et de l’augmentation de la pression artérielle. Les résultats indiquent que la rigidité artérielle altère la régulation du flux sanguin cérébral et l'intégrité du système vasculaire cérébral, endommageant la barrière hémato-encéphalique et conduisant à des déficits cognitifs. Le débit sanguin cérébral est altéré au repos ainsi qu’au niveau de ses mécanismes de régulation comme l’autorégulation cérébrale, le couplage neurovasculaire et la fonction endothéliale. Dans notre deuxième étude nous avons cherché à comprendre le dimorphisme sexuel pour la rigidité artérielle et ses conséquences sur le cerveau dans le même modèle. Nos résultats montrent que la rigidité artérielle entraîne une altération du couplage neurovasculaire et de la réactivité vasculaire dépendante de l’endothélium chez les souris mâles mais pas chez les souris femelles reproductives. Chez les souris ovariectomisées, cette protection a été supprimée, mais a été restaurée par un traitement à l’œstradiol. Dans la troisième étude, nous avons voulu étudier la possibilité de prévenir la rigidité artérielle et ses effets subséquents sur le cerveau. Pour cette étude, nous avons utilisé la vitamine K (VK) (phylloquinone ou VK1 et la ménaquinone-4 ou MK-4) vu son action anti-calcifiante et ses effets bénéfiques sur les fonctions cognitives observés dans d’autres modèles animaux et chez l’homme. Cette étude a démontré que la VK améliore les fonctions cognitives et rétablit le débit sanguin cérébral au repos et diminue la calcification vasculaire. Les capacités d’apprentissage s’amplifient avec l’apport de la VK alimentaire et la concentration de la VK au cerveau. Ces études permettent une meilleure compréhension de la rigidité artérielle et démontrent le potentiel de la VK et le traitement hormonal par l’œstradiol dans la prévention de ses effets sur le cerveau. Cependant, d’autres études sont nécessaires pour déterminer tous les mécanismes impliqués dans la protection du cerveau par la VK et l’œstradiol. / Epidemiological studies have associated arterial stiffness with cognitive decline and dementia. However, its effects on the brain biology remain unknown. In our first study, using a new murine model of arterial stiffness, we wanted to characterize the effects of arterial stiffness on the brain independently of age and pressure. Our results indicate that arterial stiffness impairs the regulation of cerebral blood flow and the integrity of the cerebrovascular system, damaging the blood-brain barrier and leading to cognitive deficits. Arterial stiffness results in significant alterations in resting cerebral blood flow and mechanisms regulating cerebral blood flow such as cerebral autoregulation, neurovascular coupling, and endothelial function. In our second study we sought to understand sexual dimorphism in arterial stiffness and its consequences on the brain in the same model. Our results show that arterial stiffness leads to impaired neurovascular coupling and endothelial-dependent vascular reactivity in male mice but not in female reproductive mice. In ovariectomized mice this protection was suppressed but was restored by estradiol treatment. In the third study, we wanted to study the possibility of preventing arterial stiffness and its subsequent effects on the brain. In this study, we used vitamin K (phylloquinone or VK1 and menaquinone-4 or MK-4) for its anti-calcifying action and its beneficial effects on the cognitive functions observed in other animal models and in humans. This study demonstrated that VK prevent cognitive impairment in part by restoring the resting cerebral blood flow but also by preventing vascular calcification. Learning abilities increase with the contribution of food VK, which in turn correlates with the VK content of the brain. These studies provide a better understanding of arterial stiffness and demonstrate the potential of VK and hormone therapy with estradiol in preventing its effects on the brain. However, further studies are needed to determine all the mechanisms involved in the brain protection by VK and estradiol.